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ABSTRACT 
Bronchiolitis obliterans organizing pneumonia (BOOP) is a lung disease that causes inflammation in the small air tubes (bronchioles) and air sacs 
(alveoli). It can be caused due to wide range of etiologies like viral infections, various drugs, chemicals, and other medical conditions. A 55 y old 
female patient presented with symptoms of BOOP who had a history for taking ayurvedic medicine (rasasindura–red mercuric sulphate) for 
rheumatoid arthritis. The patient didn’t respond to initial symptomatic therapy and the reports of High-resolution computed tomography (HRCT) 
and chest X ray revealed the diagnosis as drug induced BOOP. In search of etiologies mercuric sulphate (major ingredient of rasasindura–ayurvedic 
medicine) was confirmed among all other possible etiologies. Patient was advised to discontinue ayurvedic medicine and completely cured by 
treatment with steroids for 2 mo. She didn’t show any symptoms of relapse in 3 mo observation period. 
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INTRODUCTION 
Bronchiolitis obliterans organizing pneumonia (BOOP) is a lung 
disease that causes inflammation in the small air tubes (bronchioles) 
and air sacs (alveoli) with a cumulative incidence of six to seven cases 
per 100,000 hospital admission. The signs and symptoms of BOOP 
often include shortness of breath, dry cough, and fever. BOOP can be 
caused by viral infections, various drugs, chemicals, and other medical 
conditions. It can be diagnosed with Pulmonary Function Test (PFT), 
imaging techniques like HRCT and lung biopsy. Histology will reveal 
proliferative bronchiolitis-a nonspecific reaction with an inflammatory 
intraluminal infiltrate with mucus in the distal alveoli [1]. 
Rheumatoid arthritis (RA) is a systemic inflammatory disease that 
has a female predominance. It affects about 1% worldwide, and it is 
thought that about 40% of all rheumatoid patients have some sort of 
extra-articular manifestation. Rheumatoid disease with joint and 
pulmonary manifestations was first described in 1948. Nonspecific 
symptoms like dyspnoea and chronic cough and with prominent 
radiological manifestations are commonly seen with RA [2-4]. 
Treatment of RA includes Non Steroidal Anti-Inflammatory Drugs 
(NSAIDs), steroids, Disease-modifying antirheumatic drugs 
(DMARDs) like methotrexate, leflunomide, hydroxychloroquine and 
sulfasalazine. Long term use of drugs used to treat rheumatoid 
arthritis can also develop BOOP [5, 6]. 
Being incurable, most of the people turn to alternative therapies like 
ayurveda for the treatment for RA. Among wide range of patented 
ayurvedic products rasasindhura seems to be the commonest 
one [7]. It is chemically red mercuric sulphate. Besides arthritis 
rasasindhura have wide range of indications including fever, 
diabetes, male inferlity, hypertension etc [8]. 
CASE REPORT 
A 55 y old female patient from Calicut, Kerala, India presented with 
complaints of cough with mucoid sputum and breathlessness that 
increases on exertion (walking). She is a known case of seropositive 
rheumatoid arthritis for 6 y and under ayurveda treatment with 
rasasindhura (red mercuric sulphate), Balarishtam and 
aswagandharisham for past 6 mo. Before starting ayurvedic 
treatment patient was undergoing allopathic treatment with Tab. 
HYDROCHLOROQUINE 200 once daily and Tab. 
METHYLPREDNISOLONE 4 mg once daily for about 6 y. The above 
allopathic medications were stopped and she started the alternate 
medications (ayurveda) for arthritis, 6 mo before the presenting 
complaints. She also had a history of hypothyroidism and is on Tab. 
THYROXINE 50 mcg OD. She had no family history of rheumatoid 
arthritis and respiratory diseases. 
On the day of admission patient’s general examination showed pallor, 
mild edema on limbs and chest crackles. Objective evidences include 
elevated erythrocyte sedimentation rate (ESR) (54 mm/1st hr) and 
slightly elevated eosinophils. Peripheral capillary oxygen saturation 
(SPO2) was dropped to 90% and chest X ray showed bilateral 
infilterate and the white patches on both lungs. Pulmonologist treated 
her symptomatically with bronchodilators, mucolytics and antibiotics, 
but the symptoms persisted. On third day sputum acid fast bacilli 
(AFB) results obtained and it was negative. On day 4 HRCT scan done 
which reveals patchy areas of ground glass opacities with smooth 
intralobular septal thickening and intralobular interstitial thickening 
(crazy pavement appearance). It also showed areas of central ground 
glass opacities with denser consolidation in both lungs and confirmed 
the diagnosis as BOOP. The patient was asked to discontinue all the 
ayurvedic medicines and steroid therapy with IV PREDNISONONE 40 
mg OD was started on the day 4. After 5 d of therapy, as the symptoms 
improved IV PREDNISOLONE 40 mg replaced with oral prednisolone 
16 mg OD for 2 d. During treatment patient was also administered 
with conventional antibiotics-AZITHROMYCIN 500 mg OD for 5 d and 
LEVOFLOXACIN for next 5 d. On day 10, patient symptomatically 
improved and saturation increased to 97%. Patient got discharged 
with oral steroid (PREDNISOLONE 8 mg 1-0-0) for 2 w and advised to 
discontinue ayurvedic treatment for RA. 
 
 
Fig. 1: HRCT report
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Fig. 2: Chest X ray before and after treatment 
 
Patient discontinued the ayurvedic medications and restarted 
allopathic medication for arthritis. Rheumatologist advised her to 
restart Tab. HYDROCHLOROQUINE 200 mg OD and tab 
AZATHIOPRIM BD and suggested review in clinic after 1 mo. After 2 
w, patient reviewed in pulmonary outpatient department. She 
appeared to be symptomatically better and respiratory 
manifestations suppressed. Tab. PREDNISOLONE dose tapered from 
8 mg to 4 mg OD and advised to review after 2 w with chest X ray. 
On her second review, her chest X ray was clear without 
infiltrations. Her steroid dose is tapered to Tab. PREDNISOLONE 2 
mg OD for 2 w and 2 mg OD on alternate days for next 2 w. She 
continued her arthritis medications along with prednisolone and 
reviewed after 4 w. 
On next review prednisolone discontinued and patient advised to 
visit OP after 1 mo. Patient didn’t show any symptoms of relapse or 
recurrence after discontinuation of prednisolone therapy. 
DISCUSSION 
Bronchiolitis obliterans organizing pneumonia (BOOP) was first 
described in the early 1980s as a clinicopathologic syndrome 
characterized by sub-acute or chronic respiratory illness. 
Histopathology studies will show presence of granulation tissue in the 
bronchiolar lumen, alveolar ducts and some alveoli, associated with a 
variable degree of interstitial and airspace infiltration by mononuclear 
cells and foamy macrophages. Cough and shortness of breath for a 
period of 2 w to 2 mo usually characterizes BOOP [1]. Symptoms 
persist despite antibiotic therapy. On imaging, air space consolidation 
can be indistinguishable from chronic eosinophilic pneumonia (CEP), 
interstitial pneumonitis (acute, nonspecific and usual interstitial 
pneumonitis) neoplasm, inflammation and infection) 
Here the patient presented with all the symptoms of BOOP-cough, 
breathlessness, saturation drop, elevated ESR and eosinophil counts. 
HRCT results confirmed the diagnosis as a true case of BOOP. 
1. 
To find out etiology, patient medical and medication history were 








History of long term use of hydrochloroquine 
Exposure to mercuric sulphate in Ayurveda medicine for 
rheumatoid arthritis. 
Rheumatoid arthritis is found to be a risk factor in the development 
BOOP by the mechanism of angiogensis and infiltration [9] and here 
the HRCT also shows the similar manner of result. But if disease 
developed due to arthritis it would relapse after the discontinuation 
the BOOP medication. Here in this patient the relapse didn't occur 
after discontinuation of therapy. So we can exclude the probability 
of arthritis induced BOOP. 
There is no much evidences for hypothyroidism induced BOOP 
except a case series published by Watanabe K in 2000[10]. The 
possibility of viral infection induced BOOP can be excluded with 
HRCT report which reveals noninfectious type infiltrates and 
patches. If it was a viral infection induced BOOP, long term therapy 
is required for complete cure otherwise relapse will occur [11]. But 
in this case, patient completely cured by 2 mo of steroid therapy and 
no relapses occurred after discontinuation medicines. It strongly 
indicates that this might bedeveloped due to a drug/chemical 
exposure. So the possible etiologies are exposure to 
hydrochloroquine and red mercuric sulphate. 
Literature review shows that the hydrochlroquine can cause 
pulmonary edema and transient infiltrates [9, 12] and there is also 
evidences for hydrochloroquine induced BOOP [13]. But in this case, 
patient discontinue HYDROCHLOROQUINE therapy 6 mo the onset 
of symptoms and also after the episode of BOOP, patient restarted 
the HYDROCHLOROQUINE therapy for rheumatoid arthritis. The 
negative report to rechalleging excludes the possibility of 
hydrochloroquine being an etiology of BOOP in this patient. 
Thus we could conclude that the patient developed BOOP because of 
long term therapy with ayurvedic medicine (red mercuric sulphate). 
Literature review shows that exposure to mercury can cause 
pneumonitis, hyaline membrane formation, extensive pulmonary 
fibrosis and other respiratory complications [14, 15]. In this patient, 
clinical symptoms of BOOP appeared after the administration of 
rasasindura (red mercuric sulphate) for 6 mo and it get cured after 
discontinuing ayurvedic medicines. 
In conclusion, mercuric sulphate is yet another addition to the vast 
etiologies of BOOP. 
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